COVID-19 vaccination in patients with cancer, a rapid review

Coronavirus disease 2019 (COVID-19) vaccine development and administration have become global priorities since the beginning of the pandemic, particularly for special populations at higher risk of complications and mortality, such as patients with haematologic and solid organ malignancies. This revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehade, Laudy, Zeitoun, Jad, Lombe, Dorothy, Irshad, Sheeba, Hemelrijck, Mieke Van, Canfell, Karen, Sullivan, Richard, Mukherji, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023301/
https://www.ncbi.nlm.nih.gov/pubmed/35510135
http://dx.doi.org/10.3332/ecancer.2022.1355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023301/
https://www.ncbi.nlm.nih.gov/pubmed/35510135
http://dx.doi.org/10.3332/ecancer.2022.1355

Ejemplares similares